MSLN and gastric cancer: The ability of CAR T cells to influence gastric cancer has been extensively investigated, and includes research on epithelial growth factor receptor (EGFR) (38), epithelial cell adhesion molecule (EpCAM) (39), and mesothelin (40), and has also focused on NKG2D (41).